Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML)

Author： Kang H.J.   Shin H.Y.   Choi H.S.   Ahn H.S.  

Publisher： Elsevier

ISSN： 0145-2126

Source： Leukemia Research, Vol.28, Iss.2, 2004-02, pp. : 167-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation

By Raepple D.  

Annals of Hematology, Vol. 88, Iss. 4, 2009-04 ,pp. : 319-324

Springer Publishing Company

Access to resources Recommend Favorite

Juvenile myelomonocytic leukemia

By Kratz Christian   Niemeyer Charlotte  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 100-103

Maney Publishing

Access to resources Recommend Favorite

Central nervous system lesions due to juvenile myelomonocytic leukemia progressed in a boy undergoing first line chemotherapy

By Fukushima Hiroko  

International Journal of Hematology, Vol. 95, Iss. 5, 2012-05 ,pp. : 581-584

Springer Publishing Company

Access to resources Recommend Favorite

High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival

By Sagaster V.   Öhler L.   Berer A.   Kabrna E.   Ofner P.   Lechner K.   Geissler K.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 9-13

Springer Publishing Company

Access to resources Recommend Favorite

A Review on Leukemia and iPSC Technology: Application in Novel Treatment and Future

By  

Current Stem Cell Research & Therapy, Vol. 13, Iss. 8, 2018-11 ,pp. : 665-675

Bentham Science Publishers

Access to resources Recommend Favorite